INNOSPEC INC.
No SEC Form 4 filings for $IOSP in the last 30 days.
See all $IOSP insider activity →Innospec (IOSP) reported Q2 revenue up 12% to $491.4M, with all three segments showing growth. Net income rose to $30.8M. However, operating cash flow fell to $24.8M, and working capital changes consumed $60.9M. Margins declined in two segments, and adjusted EBITDA dropped to $93.8M. The company remains debt-free with $250.2M in net cash, paying dividends and repurchasing shares.
Innospec reported Q2 2026 revenue of $491.4 million, up 12% year over year, and net income of $30.8 million ($1.25 diluted EPS). Adjusted EPS was $1.27 and adjusted EBITDA $50.1 million. Segment results included higher Performance Chemicals, Fuel Specialties, and Oilfield Services. Management cited supply constraints from plant repairs and said DRA capacity is almost sold out.
Innospec (NASDAQ:IOSP) Q2 call: CEO Patrick Williams said Performance Chemicals benefited from operating leverage, Fuel Specialties stayed within targeted margins, and Oilfield Services improved sequentially and YoY on expanded DRA capacity. North Carolina repairs are ~60% complete, with full optimization by Q4. Management expects Q3 segment results broadly similar, plus operating-income growth in H2 2026. Cash from ops was $7.2M before $16.5M capex; $250.2M cash, no debt; repurchased 87k shares
Over the past 7 days, alphai's AI scored 1 news story mentioning IOSP (INNOSPEC INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent IOSP coverage spans financial news and earnings.
Earnings beat on top line masks cash flow weakness; investors may reassess valuation and short-term liquidity risk.
Near-term upside is capped by supply constraints and working-capital drag, while DRA capacity nearing sellout and Performance Chemicals repair progress support a stronger H2.
Earnings-call guidance and operational repair timeline suggest improving supply and margins, but near-term segment results remain constrained and lagged by input-cost pricing.
The filing provides a fresh earnings datapoint plus balance-sheet and capital return updates, supporting a near-term reassessment of fundamentals and cash flow durability.
Innospec (IOSP) exhibits moderate positive momentum due to dividend increases and share buybacks, but earnings declines suggest caution. Its relevance for trading is limited but noteworthy for small-cap stock strategies.
alphai scores every news story that mentions IOSP with an AI model for sentiment and relevance, and aggregates insider trades from INNOSPEC INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Innospec (IOSP) reported Q2 revenue up 12% to $491.4M, with all three segments showing growth. Net income rose to $30.8M. However, operating cash flow fell to $24.8M, and working capital changes consumed $60.9M. Margins declined in two segments, and adjusted EBITDA dropped to $93.8M. The company remains debt-free with $250.2M in net cash, paying dividends and repurchasing shares.
2 min readInnospec reported Q2 2026 revenue of $491.4 million, up 12% year over year, and net income of $30.8 million ($1.25 diluted EPS). Adjusted EPS was $1.27 and adjusted EBITDA $50.1 million. Segment results included higher Performance Chemicals, Fuel Specialties, and Oilfield Services. Management cited supply constraints from plant repairs and said DRA capacity is almost sold out.
6 min readInnospec (NASDAQ:IOSP) Q2 call: CEO Patrick Williams said Performance Chemicals benefited from operating leverage, Fuel Specialties stayed within targeted margins, and Oilfield Services improved sequentially and YoY on expanded DRA capacity. North Carolina repairs are ~60% complete, with full optimization by Q4. Management expects Q3 segment results broadly similar, plus operating-income growth in H2 2026. Cash from ops was $7.2M before $16.5M capex; $250.2M cash, no debt; repurchased 87k shares
5 min readINNOSPEC INC. (IOSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innospec REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent Continued strength in Fuel Specialties and further improvement in Performance Chemicals and Oilfield Services Debt-free b
4 min readInnospec Inc. (NASDAQ: IOSP) is highlighted as one of the most popular small-cap stocks, having declared an increased semi-annual dividend of $0.92 per share and a new $75 million share repurchase program. The company reported a 3% YoY revenue increase to $453.2 million in Q1 2026, though adjusted EBITDA and EPS saw declines compared to the previous year. Despite its potential, the article suggests that other AI stocks might offer greater returns in a shorter timeframe.
3 min readInnospec Inc. director Milton C. Blackmore sold 1,030 shares of the company's common stock for $84,296 on February 20, 2026. This transaction occurred amidst a nearly 8% drop in the stock price over the previous week. Concurrently, Blackmore also acquired 1,030 shares through exercising stock options and received 1,539 restricted stock units.
3 min readTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
3 min readInnospec (IOSP) delivered earnings and revenue surprises of +8.74% and +0.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2 min readContinued strength in Fuel Specialties offsetting lower than expected results in our other business segments ...
3 min readInnospec Inc's ( NYSE:IOSP ) short interest as a percent of float has risen 36.67% since its last report. According to exchange reported data, there are now 579 thousand shares sold short, which is 3.28% of all regular shares that are available for trading.
2 min read
